CVKD vs EG · $20.2M cap vs P/E 17, rev $8.03B
Cadrenal Therapeutics, Inc. Common Stock (CVKD) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
CVKD does not have a complete income-statement cache yet.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
CVKD currently screens at market cap $20.2M. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the CVKD and EG stock pages for the full models.
Not investment advice.